BJ Rimel, MD, Discusses Biggest Takeaways from 2021 SGO Annual Meeting
Rimel, of the Cedars-Sinai Medical Center, focused her attention on the main takeaways to come out from the 2021 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
BJ Rimel, MD, of the Cedars-Sinai Medical Center spoke to CancerNetwork® regarding her biggest takeaways when it comes to the data presented at the 2021 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer.
Transcription:
The biggest takeaway for the annual meeting for me is the excitement around seeing the perspectives of clinical trials, innovations in office care, [and] innovations in how we approach getting data from patients or about patients to serve them better. I really thought that was an exciting part of the meeting and I’m looking forward to seeing more of it.
![“The trial will be successful, or [we’ll] declare it a success if we see at least 3 of 24 responses overall,” stated Ravi, MD, BChir, MRCP, on the phase 2 LASER trial in RCC.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F9addaac21d809a7b642a567b0a704cbb15d87ac5-2966x1684.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=30 "“The trial will be successful, or [we’ll] declare it a success if we see at least 3 of 24 responses overall,” stated Ravi, MD, BChir, MRCP, on the phase 2 LASER trial in RCC.")
